J&J Voluntarily Recalls Tylenol Caplets Lot

Johnson & Johnson said Monday it's initiated a voluntary recall of a single lot of Tylenol caplets in response to complaints about a "musty or moldy odor."
Author:
Publish date:

NEW YORK (

TheStreet

) --

Johnson & Johnson

(JNJ) - Get Report

said Monday it's initiated a voluntary recall of a single lot of Tylenol 8-Hour caplets in response to complaints about a "musty or moldy odor."

The lot number in question is "BCM155" and the company advised consumers who have purchased the product to stop using it, and make contact with J&J to receive a refund or product coupon.

The company's McNeil Consumer Healthcare unit

announced the recall

, saying the smell was believed to have been caused by "the presence of trace amounts of a chemical called 2,4,6-tribromoanisole." It called the decision to undertake the recall a precaution and characterized the chance of an adverse medical event as "remote."

J&J shares closed Monday's regular session up 29 cents at $63.86. Year-to-date, the Dow component is down 1.3%.

The New Brunswick, N.J.-based health care products giant is slated to report its third-quarter results before Tuesday's opening bell. The current average estimate of analysts polled by

Thomson Reuters

is for a profit of $1.15 a share on revenue of $15.2 billion in the September period.

--

Written by Michael Baron in New York.

>To contact the writer of this article, click here:

Michael Baron

.

>To submit a news tip, send an email to:

tips@thestreet.com

Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.